¼¼°èÀÇ ¿ø°Ý¾à±¹(Telepharmacy) ½ÃÀå
Telepharmacy
»óǰÄÚµå : 1799211
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 144 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¿ø°Ý¾à±¹ ½ÃÀåÀº 2030³â±îÁö 406¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 117¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¿ø°Ý¾à±¹ ¼¼°è ½ÃÀåÀº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 23.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 406¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠȯÀÚ Ä«¿î¼¿¸µ ¼­ºñ½º´Â CAGR 24.6%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 206¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿ø°Ý Á¶Á¦ ¼­ºñ½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR23.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 31¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 21.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¿ø°Ý¾à±¹ ½ÃÀåÀº 2024³â¿¡ 31¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 62¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 21.8%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 21.5%¿Í 19.9%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 16.9%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¿ø°Ý¾à±¹ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿ø°Ý ¾à±¹Àº ÀÇ·á Á¢±Ù¼ºÀÇ °ÝÂ÷¸¦ ¾î¶»°Ô ÇØ¼ÒÇϰí Àִ°¡?

¿ø°Ý¾à±¹´Â Á¶Á¦, »ó´ã, Ä¡·á ¸ð´ÏÅ͸µ µîÀÇ ÀǾàǰ ¼­ºñ½º¸¦ µðÁöÅÐ Ç÷§ÆûÀ» ÅëÇØ ¿ø°ÝÀ¸·Î Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾à±¹Àº È­»ó ÅëÈ­, º¸¾È ¸Þ½Ã¡, ·Îº¿ Á¶Á¦ ÀåÄ¡¸¦ »ç¿ëÇÏ¿© ¿ÀÇÁ¶óÀÎ ¾à±¹ÀÌ ¾ø´Â Áö¹æÀ̳ª ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ªÀÇ È¯Àڵ鿡°Ô ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¾à±¹ °ü¸® ½Ã½ºÅÛÀº ó¹æÀü È®ÀÎ, ÀüÀÚ ÀÇ·á ±â·Ï ÅëÇÕ, ¼øÀÀµµ ÃßÀûÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ÆÄÀÏ·µ ÇÁ·ÎÁ§Æ®¿¡¼­ ¿ÏÀüÈ÷ ÅëÇÕµÈ ¿ø°Ý ¾à±¹ ³×Æ®¿öÅ©·ÎÀÇ ÀüȯÀº ¾à±¹À» ¹°¸®Àû Á¶Á¦ ¾à±¹»Ó¸¸ ¾Æ´Ï¶ó »ç½Ç»ó 24½Ã°£ 365ÀÏ Á¢±Ù °¡´ÉÇÑ ÀÇ·á ¼­ºñ½º Á¦°ø ³ëµå·Î ÀνÄÇÏ°Ô µÈ °ÍÀ» ¹Ý¿µÇÕ´Ï´Ù.

ÀÌ·¯ÇÑ ÁøÈ­ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ±â¼ú ¹ßÀüÀº ¹«¾ùÀΰ¡?

AI ±â¹Ý ¾à¹° °ËÅä µµ±¸´Â ÇöÀç ¾à»ç°¡ ¾à¹°-¾à¹° »óÈ£ ÀÛ¿ëÀ» ½Äº°ÇÏ°í °³º°È­µÈ ¿ë·® Á¶Á¤À» ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÚµ¿ Á¶Á¦ Ű¿À½ºÅ©¿Í ¿ø°Ý ·Îº¿ ÆÈÀ» ÅëÇØ ¿ø°ÝÁöÀÇ ±â¼úÀÚ°¡ ¾à»çÀÇ °¨½Ã ÇÏ¿¡ ¾ÈÀüÇÑ Á¶Á¦¸¦ °¨µ¶ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿ø°Ý ÀǾàǰ °ü¸® ¾ÛÀº Àçó¹æ ¾Ë¸², °¡»ó ¾Ë¾à »ï۱â ÄÚĪ, ¸¸¼ºÁúȯ »ýüÁ¤º¸ ¸ð´ÏÅ͸µ µîÀÇ ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù. ºí·ÏüÀΰú ÀüÀÚó¹æÀü ½Ã½ºÅÛÀº ó¹æÀüÀÇ º¸¾È°ú »óÈ£¿î¿ë¼ºÀ» Çâ»ó½Ã۰í, ½Ç½Ã°£ ¹ø¿ª ¸ðµâÀº ¼­ºñ½º°¡ ÃæºÐÇÏÁö ¾ÊÀº Áö¿ªÀÇ ºñ¿ø¾î¹ÎÀ» Áö¿øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ±âÁ¸ÀÇ ¿öÅ©Ç÷ο츦 À籸¼ºÇÏ¿© º¸´Ù È¿À²ÀûÀ̰í Áú ³ôÀº ȯÀÚ Áö¿øÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

¾î¶² ÀÌÇØ°ü°èÀÚÀÇ ¿ä±¸°¡ ¿ø°Ý ¾à±¹ µµÀÔÀ» ÃßÁøÇϰí Àִ°¡?

°Åµ¿ÀÌ ºÒÆíÇÑ È¯ÀÚ³ª ¸¸¼ºÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀº Åù質 ¿ø°Ý»ó´ãÀ» ÅëÇØ À̵¿ÀÇ ºÎ´ãÀ» ÁÙÀÌ°í º¹¾à ¼øÀÀµµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. °í¿ëÁÖ¿Í º¸Çè»ç´Â ¿ø°Ý¾à±¹¸¦ ÀÀ±Þ Áø·á¿Í °ü·ÃµÈ ºñ¿ëÀ» ÁÙÀ̸鼭 Áø·áÀÇ ¿¬¼Ó¼ºÀ» º¸ÀåÇÏ´Â ¹æ¹ýÀ¸·Î ÀνÄÇϰí ÀÖ½À´Ï´Ù. Àη ºÎÁ·¿¡ Á÷¸éÇÑ ¾à±¹Àº ¿ø°Ý¾à±¹¸¦ Ȱ¿ëÇÏ¿© ¾à»çÀÇ ½Ã°£À» ÀçºÐ¹èÇϰí, ½Ã°£¿Ü ¼­ºñ½º¸¦ Áö¿øÇϸç, ¼­ºñ½º ¹üÀ§¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛ°ú Áö¿ª º´¿øÀº ¿ø°Ý¾à±¹¸¦ µµÀÔÇÏ¿© ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇϰí, Áö¹æ Áø·á¼Ò ¹× ¾ß°£ ±Ù¹« ½Ã ÀüÀÚ ¾à¹° ´ëÁ¶ ±â´ÉÀ» Á¦°øÇÏ¿© ¿ø°ÝÁöÀÇ È¯ÀÚ ¾ÈÀüÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù.

¿ø°Ý¾à±¹ ½ÃÀåÀ» ¹ßÀü½ÃŰ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¿ø°ÝÁ¶Á¦ ¹× ÀüÀÚó¹æÀü °ü·Ã ±ÔÁ¦ ¿ÏÈ­, ¾à±¹ ÀÚµ¿È­ Çϵå¿þ¾î¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, Áö¼ÓÀûÀÎ Åõ¾à °ü¸®°¡ ÇÊ¿äÇÑ ¸¸¼ºÁúȯÀÇ À¯Çà, Æí¸®ÇÏ°í °¡»óÀûÀÎ Ä¡·á¸¦ ¼±È£Çϴ ȯÀÚ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ¿ø°Ý¾à±¹ ½ÃÀåÀÇ ¼ºÀåÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á Ç÷§Æû°ú ¾à±¹±Þ¿©°ü¸®(PBM)ÀÇ À¶ÇÕÀ» ÅëÇØ ÅëÇÕ ¼­ºñ½º ¹× ÁؼöÀ² ÃßÀûÀ» °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú ±â¾÷µéÀÌ ¾à±¹ ¼­ºñ½º¿¡ ÁøÃâÇϰí ÀÖÀ¸¸ç, ¾à»çµéÀº ÀϺΠÁö¿ª¿¡¼­ °ø±ÞÀÚÀÇ ÁöÀ§¸¦ ȹµæÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¼­ºñ½º(ȯÀÚ Ä«¿î¼¿¸µ ¼­ºñ½º, ¿ø°Ý Á¶Á¦ ¼­ºñ½º, ¾à¹° ¿ä¹ý ¸ð´ÏÅ͸µ ¼­ºñ½º, ¾àÀç ó¹æ Çã°¡ ¼­ºñ½º);Àü°³(On-Premise Àü°³, À¥ ±â¹Ý Àü°³, Ŭ¶ó¿ìµå ±â¹Ý Àü°³)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°è °íÀ¯ SLM¿¡ Äõ¸®-ÇÏ´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Telepharmacy Market to Reach US$40.6 Billion by 2030

The global market for Telepharmacy estimated at US$11.7 Billion in the year 2024, is expected to reach US$40.6 Billion by 2030, growing at a CAGR of 23.1% over the analysis period 2024-2030. Patient Counseling Services, one of the segments analyzed in the report, is expected to record a 24.6% CAGR and reach US$20.6 Billion by the end of the analysis period. Growth in the Remote Dispensing Services segment is estimated at 23.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 21.8% CAGR

The Telepharmacy market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 21.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.5% and 19.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.9% CAGR.

Global Telepharmacy Market - Key Trends & Drivers Summarized

How is Telepharmacy Bridging Gaps in Healthcare Access?

Telepharmacy enables remote delivery of pharmaceutical services-such as medication dispensing, counseling, and therapy monitoring-via digital platforms. Pharmacies use video calls, secure messaging, and robotic dispensing units to serve patients in rural or underserved areas lacking brick-and-mortar pharmacies. Cloud-based pharmacy management systems facilitate prescription verification, electronic health records integration, and adherence tracking. The move from pilot projects to fully integrated telepharmacy networks reflects a shift in how pharmacies are viewed-not just as physical dispensaries, but as healthcare delivery nodes accessible virtually 24/7.

What Technological Advances Are Driving This Evolution?

AI-powered medication review tools now assist pharmacists in identifying drug-drug interactions and personalized dosage adjustments. Automated dispensing kiosks and tele-robotic arms allow remote technicians to oversee safe fulfillment under pharmacist supervision. Tele-pharmaceutical care apps offer features like refill reminders, virtual pill-swallowing coaching, and biometric monitoring for chronic conditions. Blockchain and e-prescription systems improve prescription security and interoperability, while real-time translation modules support non-native speakers in underserved regions. These innovations are reshaping traditional workflow, enabling more efficient, high-quality patient support.

Which Stakeholder Needs Are Steering Telepharmacy Adoption?

Patients with mobility limitations or chronic diseases benefit from home delivery and remote counseling-reducing travel burden and enhancing medication adherence. Employers and insurers see telepharmacy as a way to ensure continuity of care while lowering costs tied to emergency visits. Pharmacies facing workforce shortages leverage telepharmacy to redistribute pharmacist time, support after-hours service, and expand service coverage. Health systems and community hospitals incorporate telepharmacy to comply with regulatory requirements and offer electronic medication reconciliation in rural clinics or during night shifts, improving patient safety in remote settings.

What Is Propelling the Telepharmacy Market Forward?

The growth in the telepharmacy market is driven by several factors including regulatory easing on remote dispensing and e-prescriptions, increased investment in pharmacy automation hardware, rising chronic disease prevalence requiring ongoing medication management, and patient preference for convenient, virtual care. The convergence of telehealth platforms with pharmacy benefit managers (PBMs) enables integrated services and enhanced adherence tracking. Technology companies are expanding into pharmacy services, and pharmacists are gaining provider status in some regions-creating a favorable environment for telepharmacy growth.

SCOPE OF STUDY:

The report analyzes the Telepharmacy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Services (Patient Counseling Services, Remote Dispensing Services, Drug Therapy Monitoring Services, Refill Authorization for Prescription Drugs Services); Deployment (On-Premise Deployment, Web-based Deployment, Cloud-based Deployment)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â